BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA-mutant ovarian cancer

Nitasha Gupta, Tzu-Ting Huang, Jayakumar R. Nair, Daniel An, Grant Zurcher, Erika J. Lampert, Ann McCoy, Ashley Cimino-Mathews, Elizabeth M. Swisher, Marc R. Radke, Christina M Lockwood, Jonathan B. Reichel, Chih-Yuan Chiang, Kelli M. Wilson, Ken Chih-Chien Cheng, Darryl Nousome, Jung-Min Lee
doi: https://doi.org/10.1101/2022.12.02.22283037

Article usage

Article usage: December 2022 to June 2025

AbstractFullPdf
Dec 2022259774
Jan 202375548
Feb 202364442
Mar 202356323
Apr 202348117
May 202334321
Jun 202329438
Jul 202333123
Aug 2023291226
Sep 202337419
Oct 202332626
Nov 2023301013
Dec 202316113
Jan 202412312
Feb 20241609
Mar 202434311
Apr 2024281018
May 20241699
Jun 202417210
Jul 20241259
Aug 202410812
Sep 2024251512
Oct 202415911
Nov 20249411
Dec 20247020
Jan 202514712
Feb 2025144415
Mar 2025275725
Apr 2025231934
May 2025202141
Jun 202512510
Back to top
Posted December 04, 2022.
Download PDF

Supplementary Material

Data/Code
Email
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA-mutant ovarian cancer
Nitasha Gupta, Tzu-Ting Huang, Jayakumar R. Nair, Daniel An, Grant Zurcher, Erika J. Lampert, Ann McCoy, Ashley Cimino-Mathews, Elizabeth M. Swisher, Marc R. Radke, Christina M Lockwood, Jonathan B. Reichel, Chih-Yuan Chiang, Kelli M. Wilson, Ken Chih-Chien Cheng, Darryl Nousome, Jung-Min Lee
medRxiv 2022.12.02.22283037; doi: https://doi.org/10.1101/2022.12.02.22283037
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area